Amneal Pharmaceuticals
AMRX
AMRX
197 hedge funds and large institutions have $997M invested in Amneal Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 84 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.43% less ownership
Funds ownership: 46.07% → 40.64% (-5.4%)
15% less capital invested
Capital invested by funds: $1.18B → $997M (-$181M)
Holders
197
Holding in Top 10
2
Calls
$3.08M
Puts
$1.2M
Top Buyers
| 1 | +$7.89M | |
| 2 | +$4.33M | |
| 3 | +$4.02M | |
| 4 |
BCP
BlackBarn Capital Partners
New York
|
+$3.47M |
| 5 |
Mariner
Overland Park,
Kansas
|
+$3.27M |
Top Sellers
| 1 | -$159M | |
| 2 | -$14.3M | |
| 3 | -$8.22M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.18M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.52M |